Showing results (1651-1660 of 2,144) with videos related to

Sort By:
Pageof 215
Blood|July 2, 2009
Generation and phenotypic analysis of protein S-deficient miceFrançois Saller, Anne C Brisset, Svetlana N Tchaikovski, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 8, 2010
VGLUT2 expression in primary afferent neurons is essential for normal acute pain and injury-induced heat hypersensitivityGrégory Scherrer, Sarah A Low, Xidao Wang, et al.
European Neurology|August 1, 2015
Diagnostic Yield of Venous Thrombosis and Pulmonary Embolism by Combined CT Venography and Pulmonary Angiography in Patients with Cryptogenic Stroke and Patent Foramen OvaleBertrand Lapergue, Jean Pierre Decroix, Serge Evrard, et al.
Acta Haematologica|October 13, 2025
Artificial Intelligence in Haematologic Diagnostics: Current Applications and Future PerspectivesAnnatina Sarah Schnegg-Kaufmann, Ulrike Bacher, Alicia Rovó, et al.
Materials Science & Engineering. C, Materials for Biological Applications|April 4, 2021
A dual-ink 3D printing strategy to engineer pre-vascularized bone scaffolds in-vitroChelsea Twohig, Mari Helsinga, Amin Mansoorifar, et al.
Advances in Experimental Medicine and Biology|November 9, 2006
Pulmonary hypertension in high-altitude dwellers: novel mechanisms, unsuspected predisposing factorsUrs Scherrer, Pierre Turini, Sébastien Thalmann, et al.
Chest|June 25, 2011
Systemic vascular dysfunction in patients with chronic mountain sicknessStefano F Rimoldi, Emrush Rexhaj, Lorenza Pratali, et al.
Neurology|September 11, 2015
A geographical cluster of progressive supranuclear palsy in northern FranceDominique Caparros-Lefebvre, Lawrence I Golbe, Vincent Deramecourt, et al.
Archives of General Psychiatry|July 13, 1999
Common genetic vulnerability for nicotine and alcohol dependence in menW R True, H Xian, J F Scherrer, et al.
British Journal of Haematology|April 7, 1999
A prospective study of risk-adapted therapy for large cell non-Hodgkin's lymphoma with VACOP-B followed by high-dose CBV and autologous progenitor cell transplantation for high-risk patients in remissionR A Stahel, L M Jost, T Kroner, et al.
Pageof 215